Search results
May 10, 2024 · Cervavac Vaccine is a vaccine used to prevent cervical, vulvar, and vaginal cancers associate with human papillomavirus (HPV) in women. it works by initiating a mild infection to stimulate the body's immune system to produce antibodies to protect against any future infections.
Sep 1, 2022 · NEW DELHI: Cervavac, India's first indigenously developed vaccine for preventing cervical cancer caused by Human Papilloma Virus ( HPV ), is likely to be priced between Rs 200-400 per dose, Serum Institute of India ( SII) CEO Adar Poonawala said on Thursday.
Nov 29, 2023 · Cervarix Vaccine is used in the treatment of Cervical cancer. View Cervarix Vaccine (prefilled syringe of 0.5 ml Suspension for Injection) uses, composition, side-effects, price, substitutes, drug interactions, precautions, warnings, expert advice and buy online at best price on 1mg.com.
Sep 1, 2022 · India launches its own cervical cancer vaccine, to cost between Rs 200-400. The qHPV vaccine, called CERVAVAC, will be manufactured by the Serum Institute of India (SII) along with the...
Gardasil vaccine protects from several diseases caused by certain types of the human papillomavirus (HPV). These include cervical cancer, vaginal and vulvar cancers in women, anal cancer, as well as some head and neck cancers. Additionally, it helps prevent genital warts in both men and women.
Meanwhile, India's first indigenously developed vaccine to prevent cervical cancer, CERVAVAC, is all set to be available later this year, costing between ₹ 200-400 a shot. CERVAVAC will be...
Feb 1, 2024 · The HPV vaccine is expected to cost the government between Rs 200 and Rs 250, which is around a tenth of the retail price. Plans are underway for the vaccination to be provided for free to females. Cervavac, SII’s domestic HPV vaccine, was made available throughout India last year.
Currently, two HPV vaccines by foreign manufacturers are available in India: the quadrivalent vaccine (Gardasil Merck), priced at ₹ 2,800 per dose; and a bivalent vaccine (Cervarix from ...
CERVAVAC ® is indicated in girls and women 9 through 26 years of age for the prevention of the following diseases caused by Human Papillomavirus (HPV) types, included in the vaccine: Cervical, vulvar, vaginal, and anal cancer caused by HPV types 16 and 18.
Cost: It is one of the major constraints for the introduction of this vaccine. What needs to be realised that the one-time cost of vaccination will help in reduction of many pre-cancerous lesions and cancerous lesions and the costs asscociated in treating them. Age:
